Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD
Ipca Labs has announced that Dr Nagaji Ambabhai Vekariya has joined the Company as President - CRD.
Dr Vekariya brings with him a professional experience of over 23 years. He started his career with Alembic Pharmaceuticals Ltd in the year 2001 and thereafter worked with companies like Glenmark Pharmaceuticals, Lupin Ltd, Aurobindo Pharma Ltd, Macleods Pharmaceuticals Ltd. & Neuland Laboratories Ltd.
Prior to joining Ipca, he was associated with Sekhmet Pharmaventures Pvt Ltd as Head - API & Formulations R&D.
Throughout his career, he has successfully led complex research initiatives, enabled global regulatory filings and played a pivotal role in advancing long term innovation strategies.
Dr Vekariya has completed his PhD in Organic Chemistry from Saurashtra University.
In March, the Medical Dialogues team reported that Ipca Labs appointed Saidutta Nanda as President - Human Resources.
Read also: IPCA Labs to Launch Maharashtra's First Fully Green Pharma Plant in Wardha
Established in 1949, lpca is a pharmaceutical company. lpca is vertically integrated and produces finished dosage forms and active pharmaceutical ingredients. For more than 70 years, lpca has been a crucial healthcare partner in over 120 countries across the globe. lpca markets its branded formulations in India and rest of the world markets and generic formulations in United States, Europe, United Kingdom, Canada, Australia & New Zealand. APls manufactured by lpca are marketed across the globe.
